Gerresheimer and Corning announce JV for Velocity Vials
Compared with conventional vials, Velocity Vials can also protect against damage that could lead to particles, breaks, and cracks
Gerresheimer announced a joint venture with Corning to increase global access to the Velocity Vial technology platform, for high quality and cost-effective injectable drug-filling process.
The partnership will combine Gerresheimer’s glass-converting expertise with Corning’s Velocity Vial technology. This model will improve fill-finish productivity and enhance product quality, lowering manufacturing costs and speeding the delivery of injectable therapies. Velocity Vials will be produced by the joint venture in existing Gerresheimer facilities for the international market, making the vials immediately available in North America, Europe and Asia.
Dr Lukas Burkhardt, Member of the Management Board of Gerresheimer, said, “By expanding our long-standing relationship with Corning, we add another integrated solution to deliver value for our customers. Our market-leading position in vials is further strengthened by this innovative vial technology. In combination with our GX Pharma Plus, Gx Elite glass vials or Gx RTF solution, we can meet the highest quality standards.”
A company statement informed, “Velocity Vials can improve filling-line efficiency by up to 50 per cent as a drop-in solution, thereby lowering costs while improving quality and providing a streamlined regulatory process. Compared with conventional vials, Velocity Vials can also protect against damage that could lead to particles, breaks, and cracks. The adoption of Velocity Vials has already helped accelerate the delivery of lifesaving treatments and critical drugs to the market.”
“Over the past two years, we’ve seen first-hand how vital Corning Velocity Vials have been to improving pharma-manufacturing performance and quality. Now, Corning is expanding access to Velocity Vials by partnering with Gerresheimer to co-manufacture and sell the product. The new model expands Velocity’s manufacturing footprint, localises its supply chains, and gives customers the option to purchase directly from Corning or Gerresheimer. We are excited to welcome Gerresheimer as the first partner to join the Velocity Vial technology platform,” said Brendan Mosher, VP and GM, Corning Pharmaceutical Technologies.